Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line- derived neurotrophic factor in patients with Parkinson's disease

Journal of Neurosurgery

Volumn 92, Issue 5, 2000, Pages 863-869

  Mendez, Ivar ^a   Dagher, Alain ^b   Hong, Murray ^b   Hebb, Adam ^b   Gaudet, Paula ^b   Law, Adam ^b   Weerasinghe, Swarna ^b   King, David ^b   Desrosiers, Jacques ^b   Darvesh, Sultan ^b   Acorn, Tanya ^b   Robertson, Harold ^b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

Glial cell line derived neurotrophic factor; Neural transplantation; Parkinson's disease; Stereotactic neurosurgery

Indexed keywords

DOPAMINE RECEPTOR; NEUROTROPHIC FACTOR;

ADULT; AGED; ARTICLE; CASE REPORT; CELL SURVIVAL; CELL TRANSPLANTATION; DOPAMINERGIC TRANSMISSION; FEMALE; FETUS CELL; GLIA CELL; GRAFT SURVIVAL; HUMAN; HUMAN CELL; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; STEREOTAXIC SURGERY; SUBSTANTIA NIGRA; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0034099045     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.92.5.0863     Document Type: Article

References (41)

1. Apostolides C, Sanford E, Hong M, et al: Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363-372, 1998
2. Brundin P, Isacson O, Björklund A: Monitoring of cell viabili~ ty in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res 331:251-259, 1985
3. Evans AC, Marrett S, Torrescorzo J, et al: MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas. J Cereb Blood Flow Metab 11:A69-A78, 1991
4. Fahn S, Elton RL, Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale, in Fahn S, Marsden CD, Goldstein M, et al (eds): Recent Developments in Parkinson's Disease, ed 2. NY: Macmillan, 1987, pp 153-163
5. Freeman TB, Olanow CW, Hauser RA, et al: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379-388, 1995
6. Frodl EM, Duan WM, Sauer H, et al: Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res 647:286-298, 1994
7. Gash DM, Zhang Z, Ovadia A, et al: Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255, 1996
8. Granholm AC, Mott JL, Bowenkamp K, et al: Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116:29-38, 1997
9. Hagell P, Schrag A, Piccini P, et al: Sequential bilateral transplantation in Parkinson's disease. Effects of the second graft. Brain 122:1121-1132, 1999
10. Hauser RA, Freeman TB, Snow BJ, et al: Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56:179-187, 1999
11. Kopyov OV, Jacques DS, Lieberman A, et al: Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 146:536-545, 1997
12. Kordower JH, Freeman TB, Chen EY, et al: Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 13:383-393, 1998
13. Kordower JH, Freeman TB, Snow BJ, et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124, 1995
14. Kordower JH, Rosenstein JM, Collier TJ, et al: Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 370:203-230, 1996
15. Langston JW, Widner H, Goetz CG, et al: Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7:2-13, 1992
16. Leenders KL, Salmon EP, Tyrrell P, et al: The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol 47:1290-1298, 1990
17. Lin LFH, Doherty DH, Lile JD, et al: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132, 1993
18. Lindvall O, Sawle G, Widner H, et al: Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35:172-180, 1994
19. Lindvall O, Widner H, Rehncrona S, et al: Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 31:155-165, 1992
20. Mehta V, Hong M, Spears J, et al: Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J Neurosurg 88:1088-1095, 1998
21. Mehta V, Spears J, Mendez I: Neural transplantation in Parkinson's disease. Can J Neurol Sci 24:292-301, 1997
22. Nakao N, Frodl EM, Duan WM, et al: Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci USA 91:12408-12412, 1994
23. Nikkhah G, Cunningham MG, Jödicke A, et al: Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633:133-143, 1994
24. Olanow CW, Kordower JH, Freeman TB: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19:102-109, 1996
25. Opacka-Juffry J, Ashworth S, Hume SP, et al: GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. Neuroreport 7:348-352, 1995
26. Patlak CS, Blasberg RG: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584-590, 1985
27. Peschanski M. Defer G, N'Guyen JP, et al: Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487-499, 1994
28. Rehncrona S: A critical review of the current status and possible developments in brain transplantation. Adv Tech Stand Neurosurg 23:3-46, 1997
29. 18F} Fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 38:580-588, 1995
30. Sauer H, Brundin P: Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor Neurol Neurosci 2:123-135, 1991
31. Schierle GS, Hansson O, Leist M, et al: Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 5:97-100, 1999
32. Sinclair SR, Svendsen CN, Torres EM, et al: GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport 7:2547-2552, 1996
33. Tabbal S, Fahn S, Fruct S: Fetal tissue transplantation in Parkinson's disease. Curr Opin Neurol 11:341-349, 1998
34. Takayama H, Ray J, Raymon HK, et al: Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat Med 1:53-58, 1995
35. Tang FI, Tien LT, Zhou FC, et al: Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Exp Brain Res 119: 287-296, 1998
36. Treanor JJS, Goodman L, de Sauvage F, et al: Characterization of a multicomponent receptor for GDNF. Nature 382:80-83, 1996
37. Vingerhoets JG, Schulzer M, Snow BJ: Reproducibility of the fluorodopa positron emission tomography indices in Parkinson's disease. Mov Disord 9 (Suppl 1):119, 1994 (Abstract)
38. Wenning GK, Odin P, Morrish P, et al: Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 42:95-107, 1997
39. Yurek DM: Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp Neurol 153:195-202, 1998
40. Yurek DM, Lu W, Hipkens S, et al: BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol 137:105-118, 1996
41. Zawada WM, Zastrow DJ, Clarkson ED, et al: Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 786:96-103, 1998